Sage Journals: Discover world-class research

Open access

Announcement

First published 2022-6

Paxlovid TM Information From FDA and Guidance for AES Members

Jon A. Cokley, Barry E. Gidal, Joy A. Keller [...]

Epilepsy Currents

Free access

Research article

First published 2022-8

Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic,Paxlovid™

Jean G. Sathish, Siddhartha Bhatt, Jamie K. DaSilva [...]

International Journal of Toxicology

Retricted access

Research article

First published 2026

Development of a pharmacist-led drug interaction assessment service for patients with cancer diagnosed with mild to moderate COVID-19 infection requiring outpatient treatment

Khushminder Dhillon, Sonia Szombathy, Mandeep Bains [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2025-1

Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists’ perspectives

Karen Dahri, Kimberley Sinclair (formerly MacNeil), Jolanta Piszczek [...]

Canadian Pharmacists Journal / Revue des Pharmaciens du Canada

Open access

Research article

First published 2025-2

Nirmatrelvir treatment duration and frequency of COVID-19 rebound

Nathan Sudeep, Noah Kojima, Jeffrey D Klausner

Antiviral Therapy

Open access

Research article

First published 2022

A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness

Tahir Amin, Aaron S. Kesselheim

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Retricted access

Research article

First published 2024-12

Supratherapeutic INR During Treatment With Nirmatrelvir/Ritonavir and Warfarin and Acute Illness With COVID-19: A Case Report

Caitlin Dowd-Green, Dannielle Brown, Alexandra Wilson [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2024-11

Predictors for COVID-19-Specific and Non-COVID-19-Specific Deaths: A Cohort Study in Taiwan

Shang-Yih Chan, Hsin-Hao Lai, Yun-Ju Lai [...]

Asia Pacific Journal of Public Health

Retricted access

Review article

First published 2023-01

Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine

Caíque Manóchio, Sabrina Torres-Loureiro, Mariana M. Scudeler [...]

OMICS: A Journal of Integrative Biology

Retricted access

Research article

First published 2022-08

4′-Fluorouridine Is a Broad-Spectrum Orally Available First-Line Antiviral That May Improve Pandemic Preparedness

Carolin M. Lieber, Richard K. Plemper

DNA and Cell Biology

Search results